IMMUNOGEN INC - COMMON STOCK (IMGN)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COMMON STOCK
Shares, excl. options Q3 2024
1
Holdings value Q3 2024
$269
Value change Q3 2024
$0
Grand Portfolio weight change Q3 2024
0%
Number of holders
1
Number of buys Q3 2024
0
Number of sells Q3 2024
0
Average buys Q3 2024 %
0
Average sells Q3 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1 $269 $0 $269.00 1
2024 Q2 1 $31.00 -$59.4K $31.00 1
2024 Q1 893 $27.8K -$7.52B $31.00 3
2023 Q4 252M $7.48B +$478M $29.65 328
2023 Q3 244M $3.87B +$224M $15.87 275
2023 Q2 224M $4.23B +$340M $18.87 267
2023 Q1 210M $806M +$5.62M $3.84 189
2022 Q4 204M $1.01B +$17.4M $4.96 197
2022 Q3 196M $935M +$2.82M $4.78 202
2022 Q2 196M $882M +$7.38M $4.50 196
2022 Q1 194M $924M -$12.7M $4.76 201
2021 Q4 190M $1.41B +$89M $7.42 215
2021 Q3 177M $1B -$25.2M $5.67 205
2021 Q2 181M $1.19B -$26.9M $6.59 197
2021 Q1 183M $1.48B +$74.5M $8.10 204
2020 Q4 174M $1.12B +$212M $6.45 198
2020 Q3 142M $511M +$6.61M $3.60 166
2020 Q2 139M $640M +$17.6M $4.60 176
2020 Q1 137M $468M +$82.4M $3.41 170
2019 Q4 112M $568M +$41.9M $5.11 176
2019 Q3 104M $252M +$5.49M $2.42 164
2019 Q2 102M $221M -$29.6M $2.17 166
2019 Q1 118M $319M -$28.9M $2.71 187
2018 Q4 123M $589M -$60.7M $4.80 180
2018 Q3 125M $1.18B -$9.75M $9.47 192
2018 Q2 126M $1.22B +$199M $9.73 182
2018 Q1 105M $1.1B +$31.2M $10.52 195
2017 Q4 104M $666M +$84M $6.41 184
2017 Q3 90.3M $691M +$109M $7.65 170
2017 Q2 76.2M $541M +$64.9M $7.11 148
2017 Q1 67.4M $261M +$25.5M $3.87 121
2016 Q4 67M $137M -$18.8M $2.04 139
2016 Q3 75.4M $202M -$17.1M $2.68 143
2016 Q2 80M $246M +$1.45M $3.08 139
2016 Q1 77M $656M -$9.5M $8.52 139
2015 Q4 77.6M $1.05B +$2M $13.57 146
2015 Q3 77.7M $746M -$3.93M $9.60 144
2015 Q2 78.8M $1.13B +$91.1M $14.38 133
2015 Q1 74.1M $663M +$50.1M $8.95 133
2014 Q4 69.3M $423M -$93M $6.10 126
2014 Q3 75.1M $795M +$11.8M $10.59 138
2014 Q2 73.8M $874M -$34.3M $11.85 134
2014 Q1 76.4M $1.14B +$14M $14.93 137